Category

Cohort News

NEMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast liquid embolic agent featuring Arsenal Medical

//
Categories
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic subdural haematoma (cSDH) via middle meningeal artery embolisation (MMAe). Research presented across multiple sessions at the...
Read More →